Ieq Capital, LLC Crispr Therapeutics Ag Transaction History

Ieq Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$70.09 - $111.29 $212,232 - $336,986	-3,028 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$110.2 - $156.64 $90,694 - $128,914	823 Added 37.32%	3,028 $339,000
Q2 2021 Jul 29, 2021	SELL	$100.84 - $161.89 $3,126 - $5,018	-31 Reduced 1.39%	2,205 $357,000
Q1 2021 May 04, 2021	BUY	$110.72 - $210.04 $247,569 - $469,649	2,236 New	2,236 $272,000

490

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.18B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ieq Capital, LLC with notifications on news.